Momentum is continuing for biosimilar switching in Canada, after Quebec’s government announced that the province would be introducing a biosimilar switching program under its public prescription drug insurance plan, similar to initiatives already being implemented in British Columbia, Alberta and New Brunswick.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?